Advanced Enzyme Technologies Limited

NSE: ADVENZYMES · Healthcare

Advanced Enzyme Technologies Limited Share Price & Analysis

321.35 +0.72%Updated 21 Jul 2026, 05:01 pm IST
LTP
321.35
+0.72%
Open
High
325
Low
317.3
Close
₹321.35
52W High
₹420
52W Low
₹252
Volume
93K
Lot Size
1
Sector
Healthcare
Market Cap
₹4K Cr
Face Value
₹2
Small Cap

Price Chart

Fundamentals

P/E
23.2
Sector P/E
54.4
P/B
2.2
EPS
₹13.61
ROE
10.2%
ROCE
14%
D/E Ratio
0.02
Div Yield
1.67%
Book Value
₹146
+

Strengths

  • Attractively valued vs sector (P/E 23.2x vs industry 54.4x)
  • Virtually debt-free
  • Regular dividends — yield 1.7%

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
1,944
₹4.6L Cr37.35.591620.50.07
DIVISLAB
Divi's Laboratories Limited
7,388
₹1.9L Cr73.411.7116.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
5,040
₹1.6L Cr73.620.3227.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,939
₹1.3L Cr64.913.5622.117.90.88
CIPLA
Cipla Limited
1,416
₹1.1L Cr30.13.3211.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
1,123
₹1.1L Cr214.1721.221.10.38
LUPIN
Lupin Limited
2,405
₹1.1L Cr19.64.928.729.90.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

ADVENZYMES · as of Mar 2026

Promoters43.08%0.16
FII11.90%0.67
DII8.19%0.02
Public36.82%0.51
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters43.62%43.50%43.02%42.95%42.92%43.08%
FII22.54%23.01%12.03%12.63%12.57%11.90%
DII6.98%7.56%8.08%8.02%8.17%8.19%
Public26.88%25.95%36.87%36.40%36.31%36.82%

Corporate Events

To consider and approve the financial results for the period ended March 31, 2026 and dividend

Dividend8 May 2026

Dividend - Rs 1.20 Per Share

Dividend22 Jul 2025

Interim Dividend - Rs 4 Per Share

Record: 16 May 2025

Dividend15 May 2025

Dividend - Re 1.1 Per Share

Dividend17 Jul 2024

Interim Dividend - Rs 4 Per Share

Record: 17 May 2024

Dividend16 May 2024

Dividend - Re 1 Per Share

Record: 4 Aug 2023

Dividend3 Aug 2023

Interim Dividend - Rs 4 Per Share

Record: 19 May 2023

Dividend18 May 2023

Latest News

All news →

TCS partners with Anthropic for enterprise AI solutions

*TCS partners with Anthropic for enterprise AI solutions*. TCS has launched a global premier partnership with AI firm Anthropic to scale enterprise AI solutions. The collaboration aims to deliver advanced AI-driven services to clients worldwide, boosting TCS's positioning in the AI space. This strategic move strengthens TCS’s AI capabilities and client offerings. 📊 *STOCKS:* TCS | 🏢 *SECTOR:* IT | #HIGHIMPACT #AI

NSE Filing11 Jun
High Impact

Persistent Systems eyes major acquisition

*Persistent Systems eyes major acquisition* — The IT firm is in advanced talks for a significant buyout, potentially exceeding ₹500Cr. This move signals aggressive expansion and vertical integration. A deal could boost scale and global delivery capabilities. 📊 *STOCKS:* PERSISTENT | 🏢 *SECTOR:* IT | #HIGHIMPACT #Acquisition

Financial Times3 Jul
High Impact

Sigma Advanced acquires UK's Bromford Precision for ₹153 cr

*Sigma Advanced acquires UK's Bromford Precision for ₹153 cr.* The acquisition strengthens Sigma’s global footprint in precision engineering for defense and aerospace. Bromford Precision adds advanced manufacturing capabilities and European clients. Deal valued at **₹153 crores** signals strategic expansion. 📊 *STOCKS:* SIGMA | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Acquisition

NSE Filing14 Jul
Medium Impact

Suven to present 5 posters at AAIC-2026 including masupirdine data

*Suven to present 5 posters at AAIC-2026 including masupirdine data*. The company will showcase updates from its **Phase-3 masupirdine** and **Phase-2 usmarapride** clinical trials at AAIC-2026 in London. These presentations highlight progress in its dementia and Alzheimer’s pipeline. Positive data could boost investor sentiment and stock movement. 📊 *STOCKS:* SUVENLIFE | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Pharma

NSE Filing10 Jul
Medium Impact

Solex Energy wins ₹628.37 crore solar module order

*Solex Energy wins ₹628.37 crore solar module order*. Solex Energy has secured a **₹628.37 crore** order for N-Type TOPCon solar modules. The order reinforces its position in the high-efficiency solar space. Demand for advanced photovoltaics is rising steadily. 📊 *STOCKS:* SOLAR | 🏢 *SECTOR:* Energy | #MEDIUMIMPACT #OrderWin

NSE Filing9 Jul
Medium Impact

ABB India wins electrification project for Kolkata Metro

*ABB India wins electrification project for Kolkata Metro*. ABB India has secured a key project to provide electrification and motion control solutions for the Kolkata Metro, enhancing system efficiency and reliability. The project underscores ABB’s growing footprint in urban infrastructure. **Jun 24, 2026** press release confirms supply and integration of advanced technology. 📊 *STOCKS:* ABB | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #OrderWin

NSE Filing24 Jun
Medium Impact

Creative Newtech partners Ravel Electronics for fire safety tech

*Creative Newtech partners Ravel Electronics for fire safety tech* to enhance India’s fire and life safety technology ecosystem. The collaboration aims to integrate advanced solutions for smarter infrastructure safety. While financial details aren’t disclosed, the strategic tie-up boosts market visibility. 📊 *STOCKS:* CREATIVENL | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Partnership

NSE Filing18 Jun
Medium Impact

Grasim inaugurates CPVC resin plant in Gujarat with Lubrizol

*Grasim inaugurates CPVC resin plant in Gujarat with Lubrizol*. Grasim Industries has inaugurated its **CPVC resin plant** at Vilayat, Gujarat, developed in collaboration with Lubrizol Advanced Materials India Private Limited. The project marks a strategic expansion in specialty chemicals with potential long-term demand growth. The plant strengthens Grasim’s position in high-margin polymer products. 📊 *STOCKS:* GRASIM | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #CPVC

NSE Filing16 Jun
Medium Impact

Kernex gets ₹100.53 crore order for tech solutions

*Kernex gets ₹100.53 crore order for tech solutions*. Kernex Microsystems India Ltd has secured an order worth **₹100.53 crores**, boosting its order book significantly. The contract is for advanced technology solutions, expected to contribute to revenue over the next 12–18 months. This win underscores growing client confidence in its technical capabilities. 📊 *STOCKS:* KERNEX | 🏢 *SECTOR:* Technology | #MEDIUMIMPACT #OrderWin

EquityBulls14 Jul
Medium Impact

MG Group secures order for 50 Starz coaches

*MG Group secures order for 50 Starz coaches.* The company unveiled its new Starz Premium Coach platform at Prawaas 2026, securing an initial order for **50 units**. This marks a strategic push into the premium commercial vehicle segment. The development highlights growing demand for advanced coach solutions in India’s transport sector. 📊 *STOCKS:* MGEQ | 🏢 *SECTOR:* Auto | #MEDIUMIMPACT #order

Prittle Prattle News10 Jul
Medium Impact

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹172 Cr
▼7.0%
₹185 Cr
▼0.5%
₹186 Cr
▲11.4%
₹167 Cr
▼1.2%
₹169 Cr
▲15.8%
₹146 Cr
▼5.8%
₹155 Cr
▼1.9%
₹158 Cr
Op. Profit
₹49 Cr
▼18.3%
₹60 Cr
▲7.1%
₹56 Cr
▲21.7%
₹46 Cr
▼16.4%
₹55 Cr
▲31.0%
₹42 Cr
▼17.6%
₹51 Cr
▼7.3%
₹55 Cr
OPM
29.0%
▼12.1%
33.0%
▲10.0%
30.0%
▲11.1%
27.0%
▼18.2%
33.0%
▲13.8%
29.0%
▼12.1%
33.0%
▼5.7%
35.0%
Net Profit
₹43 Cr
▼4.4%
₹45 Cr
▲12.5%
₹40 Cr
▲48.1%
₹27 Cr
▼30.8%
₹39 Cr
▲18.2%
₹33 Cr
▼5.7%
₹35 Cr
▲16.7%
₹30 Cr
EPS (₹)
3.8
▼1.8%
3.87
▲8.4%
3.57
▲50.6%
2.37
▼29.7%
3.37
▲14.6%
2.94
▼3.6%
3.05
▲20.6%
2.53

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹746 Cr
▲17.1%
₹637 Cr
▲2.1%
₹624 Cr
▲15.3%
₹541 Cr
▲2.3%
₹529 Cr
▲5.4%
₹502 Cr
▲13.1%
₹444 Cr
▲5.7%
₹420 Cr
▲7.4%
₹391 Cr
▲18.8%
₹329 Cr
Expenses
₹517 Cr
▲17.2%
₹441 Cr
▲5.5%
₹418 Cr
▲9.4%
₹382 Cr
▲16.8%
₹327 Cr
▲21.6%
₹269 Cr
▲11.6%
₹241 Cr
▲2.1%
₹236 Cr
▲4.4%
₹226 Cr
▲27.7%
₹177 Cr
Op. Profit
₹229 Cr
▲16.8%
₹196 Cr
▼4.9%
₹206 Cr
▲30.4%
₹158 Cr
▼22.2%
₹203 Cr
▼12.5%
₹232 Cr
▲14.3%
₹203 Cr
▲10.3%
₹184 Cr
▲11.5%
₹165 Cr
▲8.6%
₹152 Cr
OPM
31.0%
▲0.0%
31.0%
▼6.1%
33.0%
▲13.8%
29.0%
▼23.7%
38.0%
▼17.4%
46.0%
▲0.0%
46.0%
▲4.5%
44.0%
▲4.8%
42.0%
▼8.7%
46.0%
Other Income
₹46 Cr
▲39.4%
₹33 Cr
▲57.1%
₹21 Cr
▲0.0%
₹21 Cr
▲250.0%
₹6 Cr
▼33.3%
₹9 Cr
▲50.0%
₹6 Cr
▲20.0%
₹5 Cr
▲400.0%
₹1 Cr
▼66.7%
₹3 Cr
Interest
₹3 Cr
▼40.0%
₹5 Cr
▲25.0%
₹4 Cr
▲33.3%
₹3 Cr
▲0.0%
₹3 Cr
▲0.0%
₹3 Cr
▼25.0%
₹4 Cr
▼20.0%
₹5 Cr
▼44.4%
₹9 Cr
▲125.0%
₹4 Cr
Depreciation
₹40 Cr
▲8.1%
₹37 Cr
▲5.7%
₹35 Cr
▲0.0%
₹35 Cr
▲0.0%
₹35 Cr
▲25.0%
₹28 Cr
▲7.7%
₹26 Cr
▲23.8%
₹21 Cr
▲16.7%
₹18 Cr
▲38.5%
₹13 Cr
PBT
₹233 Cr
▲24.6%
₹187 Cr
▼0.5%
₹188 Cr
▲34.3%
₹140 Cr
▼18.1%
₹171 Cr
▼18.6%
₹210 Cr
▲17.3%
₹179 Cr
▲10.5%
₹162 Cr
▲16.5%
₹139 Cr
▲1.5%
₹137 Cr
Tax %
25.0%
▼10.7%
28.0%
▲3.7%
27.0%
▲3.8%
26.0%
▼7.1%
28.0%
▲0.0%
28.0%
▲7.7%
26.0%
▼7.1%
28.0%
▼15.2%
33.0%
▲3.1%
32.0%
Net Profit
₹174 Cr
▲29.9%
₹134 Cr
▼2.2%
₹137 Cr
▲31.7%
₹104 Cr
▼16.1%
₹124 Cr
▼17.9%
₹151 Cr
▲13.5%
₹133 Cr
▲14.7%
₹116 Cr
▲23.4%
₹94 Cr
▲1.1%
₹93 Cr
EPS (₹)
15.07
▲28.6%
11.72
▼1.7%
11.92
▲26.1%
9.45
▼11.7%
10.7
▼18.3%
13.09
▲13.0%
11.58
▲16.4%
9.95
▲23.3%
8.07
▼1.6%
8.2
Div Payout
9.0%
▼79.5%
44.0%
▲2.3%
43.0%
▲290.9%
11.0%
▲22.2%
9.0%
▲28.6%
7.0%
▲40.0%
5.0%
▼16.7%
6.0%
▲0.0%
6.0%
▲20.0%
5.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹22 Cr
▲0.0%
₹22 Cr
▲0.0%
₹22 Cr
▲0.0%
₹22 Cr
▲0.0%
₹22 Cr
▲0.0%
₹22 Cr
▲0.0%
₹22 Cr
▲0.0%
₹22 Cr
▲0.0%
₹22 Cr
▲0.0%
₹22 Cr
Reserves
₹1.5K Cr
▲4.6%
₹1.4K Cr
▲7.4%
₹1.3K Cr
▲7.3%
₹1.2K Cr
▲13.8%
₹1.1K Cr
▲12.4%
₹948 Cr
▲16.0%
₹817 Cr
▲24.4%
₹657 Cr
▲22.3%
₹537 Cr
▲21.5%
₹442 Cr
Borrowings
₹35 Cr
▼10.3%
₹39 Cr
▼17.0%
₹47 Cr
▲38.2%
₹34 Cr
▼2.9%
₹35 Cr
▲52.2%
₹23 Cr
▼17.9%
₹28 Cr
▼20.0%
₹35 Cr
▼47.8%
₹67 Cr
▲24.1%
₹54 Cr
Other Liabilities
₹173 Cr
▲14.6%
₹151 Cr
▲0.7%
₹150 Cr
▲5.6%
₹142 Cr
▲3.6%
₹137 Cr
▼10.5%
₹153 Cr
▲47.1%
₹104 Cr
▲14.3%
₹91 Cr
▼10.8%
₹102 Cr
▲56.9%
₹65 Cr
Total Liabilities
₹1.7K Cr
▲5.0%
₹1.6K Cr
▲5.9%
₹1.5K Cr
▲7.8%
₹1.4K Cr
▲12.0%
₹1.3K Cr
▲9.9%
₹1.1K Cr
▲18.0%
₹971 Cr
▲20.6%
₹805 Cr
▲10.7%
₹727 Cr
▲24.7%
₹583 Cr
Assets
Fixed Assets
₹683 Cr
▲0.6%
₹679 Cr
▲4.5%
₹650 Cr
▲0.2%
₹649 Cr
▲4.8%
₹619 Cr
▲3.0%
₹601 Cr
▲6.7%
₹563 Cr
▲13.7%
₹495 Cr
▲0.8%
₹491 Cr
▲16.6%
₹421 Cr
CWIP
₹31 Cr
▲40.9%
₹22 Cr
▼46.3%
₹41 Cr
▲86.4%
₹22 Cr
▲46.7%
₹15 Cr
▲50.0%
₹10 Cr
▲0.0%
₹10 Cr
▲0.0%
₹10 Cr
▼9.1%
₹11 Cr
▲37.5%
₹8 Cr
Investments
₹529 Cr
▲10.2%
₹480 Cr
▲19.1%
₹403 Cr
▲11.9%
₹360 Cr
▲252.9%
₹102 Cr
▼15.7%
₹121 Cr
▼2.4%
₹124 Cr
▲11.7%
₹111 Cr
₹0 Cr
₹0 Cr
Other Assets
₹449 Cr
▲4.4%
₹430 Cr
▲0.7%
₹427 Cr
▲12.4%
₹380 Cr
▼27.5%
₹524 Cr
▲26.9%
₹413 Cr
▲50.2%
₹275 Cr
▲46.3%
₹188 Cr
▼16.8%
₹226 Cr
▲47.7%
₹153 Cr
Total Assets
₹1.7K Cr
▲5.0%
₹1.6K Cr
▲5.9%
₹1.5K Cr
▲7.8%
₹1.4K Cr
▲12.0%
₹1.3K Cr
▲9.9%
₹1.1K Cr
▲18.0%
₹971 Cr
▲20.6%
₹805 Cr
▲10.7%
₹727 Cr
▲24.7%
₹583 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Operating CF
₹142 Cr
▲0.7%
₹141 Cr
▲0.7%
₹140 Cr
▲14.8%
₹122 Cr
▼25.2%
₹163 Cr
▲15.6%
₹141 Cr
▲9.3%
₹129 Cr
▲11.2%
₹116 Cr
▲8.4%
₹107 Cr
▲15.1%
₹93 Cr
Investing CF
₹-89 Cr
▼36.9%
₹-65 Cr
▲77.3%
₹-286 Cr
▼14400.0%
₹2 Cr
▲107.4%
₹-27 Cr
▲37.2%
₹-43 Cr
▲65.3%
₹-124 Cr
▼106.7%
₹-60 Cr
▲0.0%
₹-60 Cr
▼500.0%
₹-10 Cr
Financing CF
₹-73 Cr
▼23.7%
₹-59 Cr
▼126.9%
₹-26 Cr
▲45.8%
₹-48 Cr
▼84.6%
₹-26 Cr
▲33.3%
₹-39 Cr
▲9.3%
₹-43 Cr
▼2050.0%
₹-2 Cr
▲96.9%
₹-65 Cr
▼3.2%
₹-63 Cr
Net Cash Flow
₹-20 Cr
▼217.6%
₹17 Cr
▲109.9%
₹-171 Cr
▼328.0%
₹75 Cr
▼31.2%
₹109 Cr
▲81.7%
₹60 Cr
▲257.9%
₹-38 Cr
▼170.4%
₹54 Cr
▲400.0%
₹-18 Cr
▼185.7%
₹21 Cr
Free Cash Flow
₹108 Cr
▲14.9%
₹94 Cr
▼7.8%
₹102 Cr
▲7.4%
₹95 Cr
▼33.6%
₹143 Cr
▲58.9%
₹90 Cr
▼22.4%
₹116 Cr
▲10.5%
₹105 Cr
▲8.2%
₹97 Cr
▲10.2%
₹88 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Debtor Days
66d
▲13.8%
58d
▼14.7%
68d
▲11.5%
61d
▼3.2%
63d
▲3.3%
61d
▲19.6%
51d
▼7.3%
55d
▲0.0%
55d
▲5.8%
52d
Inventory Days
378d
▲0.8%
375d
▲9.3%
343d
▼14.7%
402d
▲16.2%
346d
▼4.2%
361d
▼0.6%
363d
▲7.1%
339d
▼3.7%
352d
▼1.7%
358d
Days Payable
41d
▲2.5%
40d
▼40.3%
67d
▲11.7%
60d
▲7.1%
56d
▲30.2%
43d
▼6.5%
46d
▼41.0%
78d
▲36.8%
57d
▼16.2%
68d
Cash Conv. Cycle
403d
▲2.5%
393d
▲14.2%
344d
▼14.9%
404d
▲14.4%
353d
▼6.9%
379d
▲2.7%
369d
▲17.1%
315d
▼10.3%
351d
▲2.6%
342d
Working Capital Days
112d
▲9.8%
102d
▼6.4%
109d
▼6.0%
116d
▲23.4%
94d
▲4.4%
90d
▲25.0%
72d
▲53.2%
47d
▼38.2%
76d
▲2433.3%
3d
ROCE
13.0%
▼13.3%
15.0%
▲25.0%
12.0%
▼25.0%
16.0%
▼27.3%
22.0%
▲0.0%
22.0%
▼8.3%
24.0%
▼4.0%
25.0%
▼19.4%
31.0%
▼13.9%
36.0%

Source: Screener.in · Lower days = better efficiency

About Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Healthcare · Pharmaceuticals & Biotechnology

Frequently Asked Questions

What is Advanced Enzyme Technologies Limited share price today?
Advanced Enzyme Technologies Limited (ADVENZYMES) is currently trading at ₹321.35 on NSE, up 0.72% as of the last market session. Prices update daily after market close on MarketNetra.
Is Advanced Enzyme Technologies Limited available in F&O (Futures & Options)?
Yes, Advanced Enzyme Technologies Limited (ADVENZYMES) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Advanced Enzyme Technologies Limited 52-week high and low?
Advanced Enzyme Technologies Limited's 52-week high is ₹420 and the 52-week low is ₹252. The current price of ₹321.35 is 23.5% below the 52W high.
What is Advanced Enzyme Technologies Limited P/E ratio?
Advanced Enzyme Technologies Limited's current P/E ratio is 23.2. This indicates the market is paying ₹23.2 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Advanced Enzyme Technologies Limited options?
Advanced Enzyme Technologies Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ADVENZYMES options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.